Skandinaviska Enskilda Banken Ab (Publ) Organon & Co. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $1,380 - $2,020	-59 Reduced 57.28%	44 $1,000
Q1 2022 May 11, 2022	SELL	$30.45 - $39.36 $578 - $747	-19 Reduced 15.57%	103 $4,000
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $1,146 - $1,485	-40 Reduced 24.69%	122 $4,000
Q3 2021 Nov 10, 2021	SELL	$28.63 - $35.64 $2.43 Million - $3.03 Million	-84,962 Reduced 99.81%	162 $5,000
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $2.42 Million - $3.23 Million	85,124 New	85,124 $2.58 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.